Showing 1 - 20 results of 30 for search 'Yu. L. Korsakova', query time: 1.10s Refine Results
  1. 1
    LIVER DAMAGE IN PSORIASIS AND PSORIATIC ARTHRITIS: A LITERATURE REVIEW

    LIVER DAMAGE IN PSORIASIS AND PSORIATIC ARTHRITIS: A LITERATURE REVIEW by Yu. L. Korsakova, T. V. Korotaeva

    Published 2017-09-01
    Get full text
    Article
  2. 2
    Apremilast: target synthetic drug for the treatment of psoriatic arthritis and psoriasis

    Apremilast: target synthetic drug for the treatment of psoriatic arthritis and psoriasis by Yu. L. Korsakova, T. V. Korotaeva

    Published 2018-07-01
    Get full text
    Article
  3. 3
    Modern pharmacotherapy of psoriatic arthritis

    Modern pharmacotherapy of psoriatic arthritis by Yu. L. Korsakova, T. V. Korotaeva

    Published 2019-03-01
    Get full text
    Article
  4. 4
    APREMILAST: AN UPDATE ON ITS EFFICACY AND SAFETY DURING LONG-TERM TREATMENT OF PATIENTS WITH PSORIATIC ARTHRITIS

    APREMILAST: AN UPDATE ON ITS EFFICACY AND SAFETY DURING LONG-TERM TREATMENT OF PATIENTS WITH PSORIATIC ARTHRITIS by Yu. L. Korsakova, T. V. Korotaeva

    Published 2018-11-01
    Get full text
    Article
  5. 5
    THE EFFICACY AND SAFETY OF THE NEW DRUG APREMILAST FOR THE TREATMENT OF PSORIASIS AND PSORIATIC ARTHRITIS

    THE EFFICACY AND SAFETY OF THE NEW DRUG APREMILAST FOR THE TREATMENT OF PSORIASIS AND PSORIATIC ARTHRITIS by Yu. L. Korsakova, L. N. Denisov

    Published 2016-12-01
    Get full text
    Article
  6. 6
    OTsENKA VYSOKIKh DOZ METOTREKSATA (MT) PRI PSORIATIChESKOM ARTRITE (PA)

    OTsENKA VYSOKIKh DOZ METOTREKSATA (MT) PRI PSORIATIChESKOM ARTRITE (PA) by V. V. Badokin, Yu L Korsakova

    Published 2005-06-01
    Get full text
    Article
  7. 7
    Experience of guselkumab usage in the treatment of patients with psoriatic arthritis in real clinical practice

    Experience of guselkumab usage in the treatment of patients with psoriatic arthritis in real clinical practice by E. Yu. Loginova, Yu. L. Korsakova, T. V. Korotaeva

    Published 2021-10-01
    Get full text
    Article
  8. 8
    Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis

    Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis by Vladimir Vasilyevich Badokin, I A Troshkina, Yu L Korsakova

    Published 2010-12-01
    Get full text
    Article
  9. 9
    Methods for the evaluation of inflammatory activity and therapy efficiency in spondyloarthritis

    Methods for the evaluation of inflammatory activity and therapy efficiency in spondyloarthritis by Alla Aleksandrovna Godzenko, Yu L Korsakova, V V Badokin

    Published 2012-06-01
    Get full text
    Article
  10. 10
    Methods for the evaluation of inflammatory activity and therapy efficiency in spondyloarthritis

    Methods for the evaluation of inflammatory activity and therapy efficiency in spondyloarthritis by Alla Aleksandrovna Godzenko, Yu L Korsakova, V V Badokin

    Published 2012-06-01
    Get full text
    Article
  11. 11
    Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis

    Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis by Vladimir Vasilyevich Badokin, I A Troshkina, Yu L Korsakova

    Published 2010-12-01
    Get full text
    Article
  12. 12
    Characteristics of patients with psoriatic arthritis treated with ustekinumab. Evidence from real-life clinical practice

    Characteristics of patients with psoriatic arthritis treated with ustekinumab. Evidence from real-life clinical practice by Yu. L. Korsakova, E. Yu. Loginova, E. E. Gubar, T. V. Korotaeva

    Published 2021-01-01
    Get full text
    Article
  13. 13
    Experience in using secukinumab in patients with axial psoriatic arthritis

    Experience in using secukinumab in patients with axial psoriatic arthritis by E. E. Gubar, Yu. L. Korsakova, E. Yu. Loginova, T. V. Korotaeva

    Published 2020-11-01
    Get full text
    Article
  14. 14
    Possibilities of screening for a high-risk axial skeletal lesion in psoriatic arthritis

    Possibilities of screening for a high-risk axial skeletal lesion in psoriatic arthritis by E. E. Gubar, E. Yu. Loginova, Yu. L. Korsakova, S. I. Glukhova, T. V. Korotaeva

    Published 2020-09-01
    Get full text
    Article
  15. 15
    EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS IN REAL CLINICAL PRACTICE

    EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS IN REAL CLINICAL PRACTICE by E. Yu. Loginova, Yu. L. Korsakova, E. E. Gubar, P. L. Karpova, T. V. Korotaeva

    Published 2020-06-01
    Get full text
    Article
  16. 16
    Therapy for psoriatic arthritis with infliximab

    Therapy for psoriatic arthritis with infliximab by V V Badokin, Yu L Korsakova, V G Barskova, M S Eliseyev, F M Kudayeva

    Published 2009-03-01
    Get full text
    Article
  17. 17
    Therapy for psoriatic arthritis with infliximab

    Therapy for psoriatic arthritis with infliximab by V V Badokin, Yu L Korsakova, V G Barskova, M S Eliseyev, F M Kudayeva

    Published 2009-03-01
    Get full text
    Article
  18. 18
    Psoriatic arthritis. Clinical guidelines for diagnosis and treatment

    Psoriatic arthritis. Clinical guidelines for diagnosis and treatment by T. V. Korotaeva, Yu. L. Korsakova, E. Yu. Loginova, E. E. Gubar, M. N. Chamurlieva

    Published 2018-06-01
    Get full text
    Article
  19. 19
    Effect of tofacitinib treatment on active MRI sacroiliitis in psoriatic arthritis patients

    Effect of tofacitinib treatment on active MRI sacroiliitis in psoriatic arthritis patients by E. E. Gubar, Yu. L. Korsakova, E. Yu. Loginova, A. V. Smirnov, S. I. Glukhova, T. V. Korotaeva

    Published 2021-05-01
    Get full text
    Article
  20. 20
    Validation of the PsAID-12 Russian questionnaire in patients with psoriatic arthritis

    Validation of the PsAID-12 Russian questionnaire in patients with psoriatic arthritis by L. D. Vorobyeva, E. Yu. Loginova, Yu. L. Korsakova, E. E. Gubar, P. O. Tremaskina, T. V. Korotaeva

    Published 2022-05-01
    Get full text
    Article

Search Tools: